◼ Archived
Health
FDA approves once-daily Parkinson’s pill (Juvmo) built on decades of work by husband-and-wife team
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 trends tracked about this subject — the full history, oldest to newest below.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The FDA has approved Juvmo, a first-in-class Parkinson's disease medication, validating AbbVie's $8.7 billion acquisition of Cerevel.
The U.S. FDA has approved AbbVie's Juvmo, a first-in-class medication designed to provide a next-generation treatment option for Parkinson's disease.